EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 191 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $931,000 | -17.8% | 22,300 | -8.4% | 0.00% | 0.0% |
| Q4 2020 | $1,133,000 | +7.4% | 24,334 | -2.0% | 0.00% | 0.0% |
| Q3 2020 | $1,055,000 | -11.6% | 24,834 | -0.2% | 0.00% | 0.0% |
| Q2 2020 | $1,194,000 | +26.1% | 24,892 | +21.0% | 0.00% | 0.0% |
| Q1 2020 | $947,000 | -72.0% | 20,579 | -63.4% | 0.00% | -66.7% |
| Q4 2019 | $3,381,000 | +1125.0% | 56,274 | +1053.4% | 0.00% | – |
| Q3 2019 | $276,000 | +34.0% | 4,879 | +64.3% | 0.00% | – |
| Q3 2018 | $206,000 | -1.0% | 2,970 | +7.8% | 0.00% | – |
| Q2 2018 | $208,000 | -40.2% | 2,754 | -68.0% | 0.00% | -100.0% |
| Q1 2016 | $348,000 | -68.6% | 8,600 | -31.2% | 0.00% | -50.0% |
| Q4 2015 | $1,108,000 | -20.8% | 12,500 | -33.9% | 0.00% | 0.0% |
| Q3 2015 | $1,399,000 | +72.9% | 18,900 | +89.0% | 0.00% | +100.0% |
| Q2 2015 | $809,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
| Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
| Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
| U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
| Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
| CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
| ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
| Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
| GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |